Berberine has emerged as a compelling natural compound for metabolic health, yet its notoriously poor bioavailability may limit its potential. This session explores a novel Berberine–Captisol® formulation designed to address this potential limitation through dramatically enhanced solubility and improved bioavailability. Discover the science behind this innovative formulation and promising human data suggesting meaningful effects on glucose regulation, lipid profiles, and cardiometabolic health, potentially opening a new chapter for berberine supplementation.
Speaker:
- Michael J. Rudolph, Ph.D., President, Excel NutraScience